Intended for UK Breelib patients, their caregivers and treating healthcare professionals

This non-promotional website is part of the Breelib Patient Support Programme and is fully funded by Bayer

Report an issue

Product Technical Complaint Form

Image CAPTCHA

Enter the characters shown in the image.

Get new captcha!

Breelib® and BreeConnect® are registered trademarks of Bayer

UK Breelib patients

This website is intended for UK Breelib patients, their caregivers and treating healthcare professionals. Breelib.co.uk is part of the Breelib Patient Support Programme which is organised and fully funded by Bayer.

Personal medical advice

Always speak to your doctor or nurse for personal medical advice. Health information on this website is not intended to replace a consultation with a healthcare professional, nor is it intended to provide specific medical advice.

Reporting of side effects and quality complaints

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard.

You can also report side effects and quality complaints to Bayer Plc. Further information is available on the "contact" tab at www.bayer.co.uk.

By reporting side effects you can help provide more information on the safety of this medicine.

  • PP-BRE-GB-0243

Date of preparation: August 2020

  • PP-BRE-GB-0243

Date of preparation: November 2020